Selective METTL1 Inhibitor Extends RNA Target Validation
A peer-reviewed Nature paper published online 28 October reports STM9005, a selective catalytic METTL1 inhibitor, with cellular tRNA-m7G target engagement and activity in AML and solid-tumor mouse models. This is a preclinical target and…
